Search results (26)
« Back to PublicationsIL-21 receptor deficiency reduces experimental atherosclerosis by modulating immune cells responses
Gurgone D. et al, (2025), ATHEROSCLEROSIS, 407, 26 - 27
Diesel exhaust particles activate macrophages and IRF5 expression in atherosclerosis
Seneviratne A. et al, (2024), EUROPEAN HEART JOURNAL, 45
Macrophage heterogeneity in cardiometabolic disease
Zurke Y. et al, (2024), EUROPEAN HEART JOURNAL, 45
A single-cell atlas of immune checkpoint molecules in atherosclerosis in ApoE-/- mice
Bazioti V. et al, (2023), EUROPEAN HEART JOURNAL, 44
Global deficiency in the inflammatory chemokine receptors 1,2,3 and 5 ameliorates atherosclerosis and selectively modulates aortic myeloid cell phenotype
Macritchie N. et al, (2023), EUROPEAN HEART JOURNAL, 44
VIRIDANS STREPTOCOCCAL BIOFILM COLONIZES ADVANCED AND COMPLICATED ATHEROSCLEROTIC ATHEROMAS BY EVADING IMMUNE SYSTEM
Karhunen PJ. et al, (2021), ATHEROSCLEROSIS, 331, E16 - E17
ESTIMATING HEART RATE IN ECHOCARDIOGRAPHY PATIENTS WHERE ECG MONITORING WAS NOT PERFORMED
Parker A. et al, (2021), JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 77, 1333 - 1333
The TAXINOMISIS Project: A multidisciplinary approach for the development of a new risk stratification model for patients with asymptomatic carotid artery stenosis.
Timmerman N. et al, (2020), Eur J Clin Invest, 50
The inflammatory role of heparan sulfate proteoglycans in human macrophages
Collins LE. et al, (2018), INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 98, A21 - A21
EXTRACELLULAR MATRIX PROTEOMICS IDENTIFIES MOLECULAR SIGNATURE OF SYMPTOMATIC CAROTID PLAQUES
Langley SR. et al, (2017), HEART, 103, A137 - A137